Ledger.Open graph →
SEC Form D · Amendment · filed September 19, 2019

Athira Pharma, Inc

Offering
$2.5M
Sold
$2.1M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
SEATTLE, WA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (10)

Gregory Alexander · New York, NYExec · DirectorRailroad Ranch Capital Management, LP · DALLAS, TXExecWalter Moos · South San Francisco, CADirectorConifer Management, L.L.C · New York, NYDirectorDouglas Stafford · Wauwatosa, WIDirectorMarc A. Schneebaum · Madison, WIExec · DirectorAndrew E. Ferrara · Madison, WIDirectorBrian F. Hegi · Dallas, TXExecWilliam P. Sims · Tomball, TXDirectorTheodore L. Ott · Atlanta, GADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗